This final chapter summarizes the key conclusions from the book, identifies key trends and suggests future directions in leading pharmaceutical innovation on three levels: (1) Increasing R&D efficiency and effectiveness; (2) redefining and rethinking the business model, and (3) leading people for innovation and change. Each of these levels is discussed in detail, breaking out the most important drivers and challenges. We conclude with a brief review of the main competencies that pharma innovators must master to remain at the forefront of their industry.
CITATION STYLE
Gassmann, O., Schuhmacher, A., von Zedtwitz, M., & Reepmeyer, G. (2018). Future Directions and Trends. In Leading Pharmaceutical Innovation (pp. 155–163). Springer International Publishing. https://doi.org/10.1007/978-3-319-66833-8_8
Mendeley helps you to discover research relevant for your work.